Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "— Chemours"


3 mentions found


J & J has said that more than 60,000 claimants support its latest proposition. This is the first J & J talc trial in about two years. JNJ YTD mountain J & J year-to-date stock performance The unresolved lawsuits against J & J have, in part, weighed on the company's stock. The MedTech and Pharmaceuticals units remained and make up the new J & J. Traders wear Johnson & Johnson coats at the NYSE.
Persons: Johnson, J's, Emory Hernandez, Hernandez, Anthony, LTL, Michael Kaplan, Kaplan, , Jim Cramer, Jim, J, Jim Cramer's, Adam Jeffery Organizations: LTL Management, J, Johnson, — Chemours, DuPont, CNBC, AAA, Pharmaceuticals, Traders, NYSE, & ' $ Locations: California, North America, U.S
Three major chemical companies on Friday said they would pay more than $1 billion to settle the first in a wave of claims that they and other companies contaminated drinking water across the country with so-called forever chemicals that have been linked to cancer and other illnesses. The companies — Chemours, DuPont and Corteva — said they had reached an agreement in principle to set up a $1.19 billion fund to help remove toxic perfluoroalkyl and polyfluoroalkyl substances, or PFAS, from public drinking water systems. Bloomberg News also reported on Friday that 3M had reached a tentative deal worth “at least $10 billion” with U.S. cities and towns to resolve related PFAS claims. Sean Lynch, a spokesman for 3M, declined to comment on the report, which cited people familiar with the deal without naming them. They have sought billions of dollars in damages to deal with the health impacts and the cost of cleaning up and monitoring polluted sites.
Persons: , Corteva —, , Sean Lynch Organizations: DuPont, Bloomberg News, 3M
Stitch Fix — Stitch Fix was up about 12%, even after the company posted downbeat quarterly numbers. General Mills — Shares of the food producer jumped 7% after the company posted a better-than-expected quarterly profit. The company now sees adjusted EBITDA between $1.4 billion and $1.45 billion, below prior guidance of $1.475 billion and $1.575 billion. Sotera Health — Sotera Health shares dropped more than 7% after JPMorgan downgraded the company to underweight from overweight, citing risks from more than 700 outstanding trials. Coty — The stock rose 5.6% after the beauty company said it has a strategy to double skincare product sales by fiscal year 2025.
Total: 3